Bora Pharmaceuticals Featured in Fierce Pharma – Bora's Quest to Join Ranks of Top CDMOs - Bora Pharmaceuticals Premium CDMO
Por um escritor misterioso
Descrição
Fierce Pharma features a discussion with CEO, Bobby Sheng in an article entitled "After Bora's biologics debut, CEO outlines quest to join ranks of top CDMOs". Published on November 10, 2022Thank you Fierce Pharma and author Fraiser Kansteiner Bora's focus on customer partnership is key to Bora's acquisition strategy. Bora's recent addition of biologics offerings
Mogene Contract Pharma
Bora Pharmaceuticals Featured in Fierce Pharma – Bora's Quest to
Bora Pharmaceuticals Premium CDMO
Bora expands its CMDO capabilities as it makes landmark
Bora Pharmaceuticals Acquires CDMO Assets From Eden Biologics
Bora Pharmaceuticals unveils new facility in Taiwan for
Careers - Bora Pharmaceuticals Premium CDMO
Careers - Bora Pharmaceuticals Premium CDMO
Mogene Contract Pharma
Mogene Contract Pharma
Technology Transfer - Bora Pharmaceuticals Premium CDMO
de
por adulto (o preço varia de acordo com o tamanho do grupo)